BC
RIGL icon

Boxer Capital’s Rigel Pharmaceuticals RIGL Stock Holding History

Boxer Capital’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-232,190
Closed -$7.45M – 26
2018
Q3 		$7.45M Hold
232,190
– – 0.83% 17
2018
Q2 		$6.57M Sell
232,190
-281,810
-55% -$10M 0.74% 21
2018
Q1 		$18.2M Buy
514,000
+200,000
+64% +$8.01M 1.94% 17
2017
Q4 		$12.2M Buy
+314,000
New +$12M 2.23% 14
2016
Q4 		– Sell
-135,114
Closed -$4.96M – 33
2016
Q3 		$4.96M Buy
135,114
+65,114
+93% +$1.87M 2.22% 14
2016
Q2 		$1.56M Buy
+70,000
New +$1.74M 1.38% 20

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital's RIGL Position: Q4 2018 in Review

Boxer Capital sold out of Rigel Pharmaceuticals (RIGL) in Q4 2018, closing a stake of 232,190 shares — an estimated $7.45M sold.

Boxer Capital first reported a position in RIGL in Q2 2016 and held it in 6 quarters. The position peaked at $18.2M in Q1 2018. 133 funds tracked by Wall St. Rank hold RIGL as of Q4 2018.

  • Boxer Capital reported no remaining Rigel Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Boxer Capital sold 232,190 Rigel Pharmaceuticals shares in Q4 2018, an estimated $7.45M.
  • Boxer Capital first reported a position in Rigel Pharmaceuticals in Q2 2016 and held it in 6 quarters.
  • Boxer Capital's Rigel Pharmaceuticals position peaked at $18.2M in Q1 2018.
  • 133 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2018.

Based on Boxer Capital's 13F filing for Q4 2018, filed 14 Feb 2019.